Karo Healthcare delivers smart choices for everyday healthcare, owning and commercialising branded, original over-the-counter products and prescription medicines across seven distinct categories including intimate health, skin health, digestive health, foot health, pain, cough and cold, wellness, and specialty products. The company's portfolio includes strong consumer healthcare brands such as E45, Lamisil, Pevaryl, Nutravita, and Multi-Gyn, with products available in more than 90 countries worldwide. Karo Healthcare operates with its own sales organization in more than 10 European countries, maintaining Europe and the Nordic region as core markets.
Guided by a purpose to help people stay in good health, Karo Healthcare empowers consumers to make smarter choices that increase their quality of life and help them live life to the fullest. The company's approach focuses on addressing, treating, and preventing the health-related problems people face in their daily lives, not just severe illness or hospitalization. With a workforce of approximately 460 colleagues across 13 countries and revenue exceeding €500 million, Karo Healthcare leverages a Scaled Entrepreneurship model with cross-functional squad teams leading self-empowered work with specific brands or categories, combining diverse perspectives to drive innovation and growth in everyday healthcare.